Holen Sie sich die Stockscreener-App
26.94
6.88%
-1.99
Vorhandelsmarkt:
27.52
0.58
+2.15%
Schlusskurs vom Vortag:
$28.93
Offen:
$28.76
24-Stunden-Volumen:
466.50K
Relative Volume:
0.61
Marktkapitalisierung:
$983.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.74%
1M Leistung:
-5.61%
6M Leistung:
+137.78%
1J Leistung:
+9.42%
1-Tages-Spanne:
$26.35
$29.49
1-Wochen-Bereich:
$25.95
$29.49
52-Wochen-Spanne:
$7.13
$42.27
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
99 HIGH STREET, BOSTON
Vergleichen Sie RAPP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
26.94 | 1.33B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-16 | Eingeleitet | Truist | Buy |
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-08 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Eingeleitet | Jefferies | Buy |
| 2024-07-02 | Eingeleitet | Stifel | Buy |
| 2024-07-02 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Has Rapport Therapeutics Inc. formed a bullish divergence2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
What institutional flow reveals about Rapport Therapeutics Inc.Weekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
Can trapped investors hope for a rebound in Rapport Therapeutics Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Down 33.3% in October - MarketBeat
Using R and stats models for Rapport Therapeutics Inc. forecastingMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Historical volatility pattern of Rapport Therapeutics Inc. visualizedGold Moves & Real-Time Chart Breakout Alerts - newser.com
Rapport Therapeutics Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Analyzing Rapport Therapeutics Inc. with risk reward ratio charts2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
How to recover losses in Rapport Therapeutics Inc. stock2025 Year in Review & Momentum Based Trading Ideas - newser.com
Why Rapport Therapeutics Inc. stock is a value investor pickJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
What earnings revisions data tells us about Rapport Therapeutics Inc.July 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
What candlestick patterns are forming on Rapport Therapeutics Inc.Trade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Will Rapport Therapeutics Inc. benefit from macro trendsWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to monitor Rapport Therapeutics Inc. recovery probabilityTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Rapport Therapeutics’ RAP-219 Study: A Potential Game-Changer for Bipolar I Disorder - MSN
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 8.1%Still a Buy? - MarketBeat
Is Rapport Therapeutics Inc a good long term investmentEconomic Indicators Overview & Outstanding Return Portfolio - earlytimes.in
Published on: 2025-10-28 05:44:22 - newser.com
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham | Chief Executive Officer |
Oct 15 '25 |
Sale |
25.81 |
5,833 |
150,541 |
579,579 |
| Ceesay Abraham | Chief Executive Officer |
Oct 15 '25 |
Sale |
25.81 |
5,083 |
131,189 |
41,061 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):